AES-350 - HY-138831
Nur noch %1 verfügbar
Catalog #
HY-138831
Ab
330,00 €
AES-350 is a potent and orally active HDAC6 inhibitor with an IC50 and a Ki of 0.0244 μM and 0.035 μM, respectively. AES-350 is also against HDAC3, HDAC8 in an enzymatic activity assay with IC50 values of 0.187 μM and 0.245 μM, respectively. AES-350 triggers apoptosis in AML cells through HDAC inhibition and can be used for acute myeloid leukemia (AML) research[1].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-138831/AES-350-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | Cancer-programmed cell death |
| CAS | 847249-57-4 |
| Storage | 4°C (Powder, protect from light) |
| MWT | 312.36 |
| Solubility | DMSO : 100 mg/mL (ultrasonic) |
| Clinical Information | No Development Reported |
| Target | Apoptosis;HDAC |
| Application: | Cancer-programmed cell death |
|---|